Boomerang Ventures

Boomerang Ventures
Menu
STUDIO APPLICATION
FUND APPLICATION
BOOMERANG

NEWS

Keep up with Boomerang Ventures as we launch new companies, engage new investors, close fundraising rounds, share industry insights, and achieve other significant milestones in the life of our team and portfolio companies.
Learn More

Back to News Page

In the News
In The news

SynchNeuro Secures Seed Funding From Boomerang Ventures

Source: CityBiz
SynchNeuro, a Philadelphia-based health-technology startup founded by neurosurgeon Dr. Casey Halpern, has secured seed funding from Boomerang Ventures. The company is developing a non-invasive EEG-based platform that decodes brain-signal activity into metabolic insights, aiming to support individuals with prediabetes and early-stage Type 2 diabetes. The investment will help expand operations and accelerate product development.

Read More »
11/25/2025
Press Release: Boomerang Ventures Leads $2M Seed Round for SiteLabs
Press Releases

Boomerang Ventures Leads Oversubscribed $2M Seed Round Investment in SiteLabs to Transform Independent Pharmacies into Frontline Hubs for Preventive Care and Research

Boomerang Ventures has led a $2 million Seed Round for SiteLabs, a health tech startup transforming independent pharmacies into neighborhood hubs for preventive care and clinical research. With $1 million invested by Boomerang and additional backing from Labcorp Venture Fund and SC Launch, the funding will accelerate SiteLabs’ platform expansion to empower pharmacies with diagnostic tools, trial recruitment capabilities, and integrations that improve access, equity, and outcomes in healthcare.

Read More »
10/29/2025
In the News
In The news

Boomerang Ventures Commits $1M to Fuel Sonara Health’s Hybrid Methadone Platform Expansion

Source: Tech Point
Boomerang Ventures has invested $1 million in Sonara Health, a Dallas-based health tech company, to scale its hybrid methadone treatment platform nationwide. The platform combines in-person care with virtual tools — including a Virtual Dosing Window™ that lets patients scan QR codes and record dose videos — aiming to reduce daily clinic visits, enhance adherence, and improve outcomes for those with opioid use disorder.

Read More »
09/23/2025
In the News
In The news

Boomerang Ventures Backs Sonara Health with $1M to Expand Hybrid Methadone Care

Source: Associated Press
Boomerang Ventures has invested $1 million in Sonara Health to expand its hybrid methadone care model nationwide. Sonara’s platform combines in-person treatment with digital tools that improve access, compliance, and outcomes for patients in opioid treatment programs. The investment will support scaling operations, advancing technology, and partnering with providers to address the growing opioid crisis.

Read More »
09/23/2025
Mentavi Health Research Study, J Clin Psychiatry, photo credit: Daenin
Insights

Validity of an Online Assessment of Attention-Deficit/Hyperactivity Disorder Among a Real-World Sample of Adults Seeking Web-Based Mental Health Care

Source: The Journal of Clinical Psychiatry
Mentavi Health, a Portfolio Company of Boomerang Ventures, is the lead author of a groundbreaking study published in the Journal of Clinical Psychiatry, “Validity of an Online Assessment of Attention-Deficit/Hyperactivity Disorder Among a Real-World Sample of Adults Seeking Web-Based Mental Health Care.” The research validates the accuracy of Mentavi’s online ADHD assessment in a real-world sample of adults seeking web-based mental healthcare. Findings demonstrate strong diagnostic agreement with clinician-led interviews and highlight the tool’s high positive predictive value, providing a clinically reliable and scalable solution to expand access to ADHD evaluation.

Read More »
09/08/2025
In the News
In The news

TechPoint Spotlights HabitHalo Quit Vaping App Launch

Source: TechPoint
TechPoint featured HabitHalo, a Boomerang Ventures portfolio company, for the launch of its Quit Vaping App. The article spotlights HabitHalo’s mission to empower users with real-time tracking, personalized plans, and motivational tools to support a nicotine-free life. Designed by founder Phil Tran and supported by Boomerang Ventures, the app is a meaningful step forward in connected health innovation.

Read More »
04/02/2025
In the News
In The news

HabitHalo Partners with Boomerang Studio to Launch PuffPal: Revolutionizing Vaping Cessation with Personalized AI Motivation App

Source: CX Dive
CX Dive reports that HabitHalo, an early-stage health tech company, has launched PuffPal, an AI-driven app designed to deliver real-time, on-demand, and personalized motivation for individuals quitting vaping. In partnership with Boomerang Studio, PuffPal provides tailored support using AI-powered messaging to help users overcome cravings and stay on track.

Read More »
01/31/2025

Back to News Page

Boomerang Ventures
Loading...